Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-M2-9643	Liposomal nanoparticles loaded with simvastatin, surface modified with CY5.5,100nm	Liposomal nanoparticles can be designed to target specific tissues or cells, such as cancer cells or neurons, enhancing the therapeutic effect of simvastatin while minimizing systemic exposure and associated side effects.The CY5.5 modification enables non-invasive imaging studies to monitor the biodistribution and accumulation of these liposomes in real time, which is crucial for understanding therapeutic efficacy and optimizing drug delivery strategies.	price>
R-M2-9668	MnO Nanoparticles,spherical 50-100nm	Manganese oxide nanoparticles (MnO) represent a versatile class of nanomaterials with distinctive properties that enable a wide variety of applications across multiple fields, including catalysis, energy storage, medical applications, and environmental remediation. Various synthesis methods can be tailored to achieve specific properties and enhance their functionality.	price>
R-M2c-9671	Bi2S3-CeO2-phenylanine nanoparticles	The hybrid nanoparticles may find application as contrast agents in imaging techniques like MRI or fluorescence imaging due to potential of phenylalanine interaction with biological systems.Phenylalanine can aid in targeting specific cells or tissues, making the nanoparticles suitable for drug delivery applications.These nanoparticles could be utilized in biosensors or diagnostic tools due to their biocompatible nature and potential for specific molecular recognition. The integration of Bi2S3-CeO2-phenylanine nanoparticles/Phenylalanine modified CeO2-Bi2S3 nanomaterials opens up exciting prospects for biomedical applications, combining the strengths of inorganic materials with biological components. These hybrid nanoparticles have the potential to revolutionize areas such as drug delivery, imaging, and biosensing, offering tailored solutions for various biomedical challenges.	price>
R-M1-8671	Folic acid modified cationic liposome encapsulation plasmid and ICG (100-200nm)	Folic acid modified cationic liposome encapsulation of plasmid and ICG (100-200nm) from ruixibio.Cationic liposomes are lipid-based nanoparticles with a positive charge due to the presence of cationic lipids. These nanoparticles are commonly used for the encapsulation and delivery of genetic material, such as plasmid DNA, to target cells for gene therapy applications.In this case, the cationic liposomes are modified with folic acid, which acts as a targeting ligand. Folic acid receptors are often overexpressed on the surface of certain cancer cells, providing a way to specifically target these cells. By modifying the liposomes with folic acid, they can enhance cellular uptake by cancer cells that express higher levels of folate receptors.The plasmid DNA within the liposomes may contain therapeutic genes or other genetic material that can be delivered to the target cells for specific applications, such as gene therapy. Meanwhile, the indocyanine green (ICG) dye serves as both a fluorescent marker and a near-infrared (NIR) imaging agent that can provide real-time monitoring and imaging of the targeted cells.	price>
R-M1-8673	Liposome encapsulated Ce6	Liposome encapsulated Ce6/Liposome@Ce6/Liposome encapsulated chlorin e6/Chlorin e6 (Ce6)-loaded liposome can be used for in vitro and in vivo experiments, as well as research on drug delivery.Because its Chlororin e6 (Ce6) is a photosensitizer material, it can have therapeutic effects on pathogens. In order to improve the efficacy of photosensitizers, various drug delivery systems have been developed. In these carrier systems, liposomes demonstrate their PDT efficacy and safety in delivering photosensitizers.	price>
R-M1-8682	ICG@liposome-cRGD,100nm	ICG@liposome-cRGD is a multifunctional complex that combines the imaging capabilities of ICG, the drug delivery properties of liposomes, and the targeting ability of cRGD peptides. Its potential applications in biomedical research include targeted imaging, drug delivery, and theranostics (combined therapy and diagnostics).	price>
R-M1-8683	FAM@LNP(100nm)	FAM@liposome nanoparticles combine the fluorescent properties of FAM with the drug delivery capabilities of liposomes. This complex provides a versatile system for fluorescence imaging, cellular tracking, and targeted drug delivery in various biomedical applications.	price>
R-M1-8688	ICG@PLGA @Liposome 100nm	ICG@PLGA @Liposome,100nm/Indocyanine green@PLGA @Liposome nanoparticles,100nm used as drug delivery carriers, photosensitizers for photothermal therapy or photodynamic therapy etc.	price>
R-M1-8693	Liposome encapsulated IR780	Liposome-Encapsulated IR780 refers to the process of incorporating the near-infrared dye IR780 into liposomes. IR780 is a hydrophobic dye that exhibits strong absorption and fluorescence in the near-infrared region of the spectrum. Liposomes, on the other hand, are lipid-based vesicles that can entrap hydrophobic molecules within their lipid bilayers or aqueous core.	price>
R-M1-8715	Rhodamine B modified gold nanoparticles,50nm	Rhodamine B-gold nanoparticles(50nm)/Gold nanoparticles modified with rhodamine B/Rhodamine B (RhB)-gold nanoparticles(50nm)/Gold nanoparticles (AuNP) modified with rhodamine B can be used for fluorescence imaging, cellular tracking, biosensing, and targeted drug delivery, among other applications.	price>

...